Molecular insights into metabotropic glutamate receptor allosteric modulations

Karen J. Gregory, P. Jeffrey Conn

Research output: Contribution to journalShort SurveyResearchpeer-review

23 Citations (Scopus)

Abstract

The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein-coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where they mediate modulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molecular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allosteric ligands. In recent years we have made significant progress in our understanding of this molecular complexity coupled with an increased understanding of the structural basis of mGlu allosteric modulation.

Original languageEnglish
Pages (from-to)188-202
Number of pages15
JournalMolecular Pharmacology
Volume88
Issue number1
DOIs
Publication statusPublished - 1 Jul 2015

Cite this

@article{ee67fafb921c419bbd4f613d28d98fc9,
title = "Molecular insights into metabotropic glutamate receptor allosteric modulations",
abstract = "The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein-coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where they mediate modulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molecular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allosteric ligands. In recent years we have made significant progress in our understanding of this molecular complexity coupled with an increased understanding of the structural basis of mGlu allosteric modulation.",
author = "Gregory, {Karen J.} and Conn, {P. Jeffrey}",
year = "2015",
month = "7",
day = "1",
doi = "10.1124/mol.114.097220",
language = "English",
volume = "88",
pages = "188--202",
journal = "Molecular Pharmacology",
issn = "1521-0111",
publisher = "ACS Books",
number = "1",

}

Molecular insights into metabotropic glutamate receptor allosteric modulations. / Gregory, Karen J.; Conn, P. Jeffrey.

In: Molecular Pharmacology, Vol. 88, No. 1, 01.07.2015, p. 188-202.

Research output: Contribution to journalShort SurveyResearchpeer-review

TY - JOUR

T1 - Molecular insights into metabotropic glutamate receptor allosteric modulations

AU - Gregory, Karen J.

AU - Conn, P. Jeffrey

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein-coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where they mediate modulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molecular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allosteric ligands. In recent years we have made significant progress in our understanding of this molecular complexity coupled with an increased understanding of the structural basis of mGlu allosteric modulation.

AB - The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein-coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where they mediate modulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molecular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allosteric ligands. In recent years we have made significant progress in our understanding of this molecular complexity coupled with an increased understanding of the structural basis of mGlu allosteric modulation.

UR - http://www.scopus.com/inward/record.url?scp=84939627772&partnerID=8YFLogxK

U2 - 10.1124/mol.114.097220

DO - 10.1124/mol.114.097220

M3 - Short Survey

C2 - 25808929

AN - SCOPUS:84939627772

VL - 88

SP - 188

EP - 202

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 1521-0111

IS - 1

ER -